Predictors of Recurrence after Catheter Ablation of Paroxysmal Atrial Fibrillation in Different Follow-Up Periods

<i>Background and objectives:</i> Pulmonary vein (PV) reconnection is a major reason for recurrence after catheter ablation of paroxysmal atrial fibrillation (PAF). However, the timing of the recurrence varies between patients, and recurrence >1 year after ablation is not uncommon. We...

Full description

Bibliographic Details
Main Authors: Masako Baba, Kentaro Yoshida, Yoshihisa Naruse, Ai Hattori, Yoshiaki Yui, Akira Kimata, Yoko Ito, Yasuaki Tsumagari, Hidekazu Tsuneoka, Yasutoshi Shinoda, Tomohiko Harunari, Yuichi Hanaki, Hideyuki Hasebe, Masako Misaki, Daisuke Abe, Akihiko Nogami, Masaki Ieda, Noriyuki Takeyasu
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1010-660X/56/9/465
id doaj-5bf517558a77450da10b2be67f39af80
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Masako Baba
Kentaro Yoshida
Yoshihisa Naruse
Ai Hattori
Yoshiaki Yui
Akira Kimata
Yoko Ito
Yasuaki Tsumagari
Hidekazu Tsuneoka
Yasutoshi Shinoda
Tomohiko Harunari
Yuichi Hanaki
Hideyuki Hasebe
Masako Misaki
Daisuke Abe
Akihiko Nogami
Masaki Ieda
Noriyuki Takeyasu
spellingShingle Masako Baba
Kentaro Yoshida
Yoshihisa Naruse
Ai Hattori
Yoshiaki Yui
Akira Kimata
Yoko Ito
Yasuaki Tsumagari
Hidekazu Tsuneoka
Yasutoshi Shinoda
Tomohiko Harunari
Yuichi Hanaki
Hideyuki Hasebe
Masako Misaki
Daisuke Abe
Akihiko Nogami
Masaki Ieda
Noriyuki Takeyasu
Predictors of Recurrence after Catheter Ablation of Paroxysmal Atrial Fibrillation in Different Follow-Up Periods
Medicina
atrial fibrillation
ablation
recurrence
natriuretic peptide
remodeling
author_facet Masako Baba
Kentaro Yoshida
Yoshihisa Naruse
Ai Hattori
Yoshiaki Yui
Akira Kimata
Yoko Ito
Yasuaki Tsumagari
Hidekazu Tsuneoka
Yasutoshi Shinoda
Tomohiko Harunari
Yuichi Hanaki
Hideyuki Hasebe
Masako Misaki
Daisuke Abe
Akihiko Nogami
Masaki Ieda
Noriyuki Takeyasu
author_sort Masako Baba
title Predictors of Recurrence after Catheter Ablation of Paroxysmal Atrial Fibrillation in Different Follow-Up Periods
title_short Predictors of Recurrence after Catheter Ablation of Paroxysmal Atrial Fibrillation in Different Follow-Up Periods
title_full Predictors of Recurrence after Catheter Ablation of Paroxysmal Atrial Fibrillation in Different Follow-Up Periods
title_fullStr Predictors of Recurrence after Catheter Ablation of Paroxysmal Atrial Fibrillation in Different Follow-Up Periods
title_full_unstemmed Predictors of Recurrence after Catheter Ablation of Paroxysmal Atrial Fibrillation in Different Follow-Up Periods
title_sort predictors of recurrence after catheter ablation of paroxysmal atrial fibrillation in different follow-up periods
publisher MDPI AG
series Medicina
issn 1010-660X
publishDate 2020-09-01
description <i>Background and objectives:</i> Pulmonary vein (PV) reconnection is a major reason for recurrence after catheter ablation of paroxysmal atrial fibrillation (PAF). However, the timing of the recurrence varies between patients, and recurrence >1 year after ablation is not uncommon. We sought to elucidate the characteristics of atrial fibrillation (AF) that recurred in different follow-up periods. <i>Materials and Methods:</i> Study subjects comprised 151 consecutive patients undergoing initial catheter ablation of PAF. Left atrial volume index (LAVi) and atrial/brain natriuretic peptide (ANP/BNP) levels were systematically measured annually over 3 years until AF recurred. <i>Results:</i> Study subjects were classified into four groups: non-recurrence group (<i>n</i> = 84), and short-term- (within 1 year) (<i>n</i> = 30), mid-term- (1–3 years) (<i>n</i> = 26), and long-term-recurrence group (>3 years) (<i>n</i> = 11). The short-term-recurrence group was characterized by a higher prevalence of diabetes mellitus (hazard ratio 2.639 (95% confidence interval, 1.174–5.932), <i>p</i> = 0.019 by the Cox method), frequent AF episodes (≥1/week) before ablation (4.038 (1.545–10.557), <i>p</i> = 0.004), and higher BNP level at baseline (per 10 pg/mL) (1.054 (1.029–1.081), <i>p</i> < 0.0001). The mid-term-recurrence group was associated with higher BNP level (1.163 (1.070–1.265), <i>p</i> = 0.0004), larger LAVi (mL/m<sup>2</sup>) (1.033 (1.007–1.060), <i>p</i> = 0.013), and longer AF cycle length at baseline (per 10 ms) (1.194 (1.058–1.348), <i>p</i> = 0.004). In the long-term-recurrence group, the ANP and BNP levels were low throughout follow-up, as with those in the non-recurrence group, and AF cycle length was shorter (0.694 (0.522–0.924), <i>p</i> = 0.012) than those in the other recurrence groups. <i>Conclusions:</i> Distinct characteristics of AF were found according to the time to first recurrence after PAF ablation. The presence of secondary factors beyond PV reconnections could be considered as mechanisms for the recurrence of PAF in each follow-up period.
topic atrial fibrillation
ablation
recurrence
natriuretic peptide
remodeling
url https://www.mdpi.com/1010-660X/56/9/465
work_keys_str_mv AT masakobaba predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods
AT kentaroyoshida predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods
AT yoshihisanaruse predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods
AT aihattori predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods
AT yoshiakiyui predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods
AT akirakimata predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods
AT yokoito predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods
AT yasuakitsumagari predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods
AT hidekazutsuneoka predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods
AT yasutoshishinoda predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods
AT tomohikoharunari predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods
AT yuichihanaki predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods
AT hideyukihasebe predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods
AT masakomisaki predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods
AT daisukeabe predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods
AT akihikonogami predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods
AT masakiieda predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods
AT noriyukitakeyasu predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods
_version_ 1724612347861925888
spelling doaj-5bf517558a77450da10b2be67f39af802020-11-25T03:21:56ZengMDPI AGMedicina1010-660X2020-09-015646546510.3390/medicina56090465Predictors of Recurrence after Catheter Ablation of Paroxysmal Atrial Fibrillation in Different Follow-Up PeriodsMasako Baba0Kentaro Yoshida1Yoshihisa Naruse2Ai Hattori3Yoshiaki Yui4Akira Kimata5Yoko Ito6Yasuaki Tsumagari7Hidekazu Tsuneoka8Yasutoshi Shinoda9Tomohiko Harunari10Yuichi Hanaki11Hideyuki Hasebe12Masako Misaki13Daisuke Abe14Akihiko Nogami15Masaki Ieda16Noriyuki Takeyasu17Department of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, JapanDepartment of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, Japan<i>Background and objectives:</i> Pulmonary vein (PV) reconnection is a major reason for recurrence after catheter ablation of paroxysmal atrial fibrillation (PAF). However, the timing of the recurrence varies between patients, and recurrence >1 year after ablation is not uncommon. We sought to elucidate the characteristics of atrial fibrillation (AF) that recurred in different follow-up periods. <i>Materials and Methods:</i> Study subjects comprised 151 consecutive patients undergoing initial catheter ablation of PAF. Left atrial volume index (LAVi) and atrial/brain natriuretic peptide (ANP/BNP) levels were systematically measured annually over 3 years until AF recurred. <i>Results:</i> Study subjects were classified into four groups: non-recurrence group (<i>n</i> = 84), and short-term- (within 1 year) (<i>n</i> = 30), mid-term- (1–3 years) (<i>n</i> = 26), and long-term-recurrence group (>3 years) (<i>n</i> = 11). The short-term-recurrence group was characterized by a higher prevalence of diabetes mellitus (hazard ratio 2.639 (95% confidence interval, 1.174–5.932), <i>p</i> = 0.019 by the Cox method), frequent AF episodes (≥1/week) before ablation (4.038 (1.545–10.557), <i>p</i> = 0.004), and higher BNP level at baseline (per 10 pg/mL) (1.054 (1.029–1.081), <i>p</i> < 0.0001). The mid-term-recurrence group was associated with higher BNP level (1.163 (1.070–1.265), <i>p</i> = 0.0004), larger LAVi (mL/m<sup>2</sup>) (1.033 (1.007–1.060), <i>p</i> = 0.013), and longer AF cycle length at baseline (per 10 ms) (1.194 (1.058–1.348), <i>p</i> = 0.004). In the long-term-recurrence group, the ANP and BNP levels were low throughout follow-up, as with those in the non-recurrence group, and AF cycle length was shorter (0.694 (0.522–0.924), <i>p</i> = 0.012) than those in the other recurrence groups. <i>Conclusions:</i> Distinct characteristics of AF were found according to the time to first recurrence after PAF ablation. The presence of secondary factors beyond PV reconnections could be considered as mechanisms for the recurrence of PAF in each follow-up period.https://www.mdpi.com/1010-660X/56/9/465atrial fibrillationablationrecurrencenatriuretic peptideremodeling